Marshall Wace’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-604,481
| Closed | -$4.2M | – | 3202 |
|
|
2025
Q4 | $4.2M | Sell |
604,481
-208,598
| -26% | -$1.37M | ﹤0.01% | 1234 |
|
|
2025
Q3 | $5.24M | Buy |
813,079
+701,079
| +626% | +$4.79M | 0.01% | 1168 |
|
|
2025
Q2 | $746K | Sell |
112,000
-615,012
| -85% | -$3.16M | ﹤0.01% | 1983 |
|
|
2025
Q1 | $4.7M | Buy |
+727,012
| New | +$5.22M | 0.01% | 1097 |
|
|
2023
Q3 | – | Sell |
-56,586
| Closed | -$453K | – | 2202 |
|
|
2023
Q2 | $453K | Sell |
56,586
-70,789
| -56% | -$522K | ﹤0.01% | 2021 |
|
|
2023
Q1 | $1.03M | Buy |
+127,375
| New | +$1.02M | ﹤0.01% | 1796 |
|
|
2022
Q4 | – | Sell |
-738,849
| Closed | -$5.09M | – | 2937 |
|
|
2022
Q3 | $5.09M | Buy |
+738,849
| New | +$5.13M | 0.01% | 1354 |
|
|
2022
Q2 | – | Sell |
-307,874
| Closed | -$7.04M | – | 3423 |
|
|
2022
Q1 | $7.04M | Buy |
+307,874
| New | +$7.53M | 0.01% | 1133 |
|
|
2021
Q1 | – | Sell |
-100,311
| Closed | -$2.09M | – | 2478 |
|
|
2020
Q4 | $2.09M | Buy |
+100,311
| New | +$1.87M | 0.01% | 931 |
|
|
2020
Q3 | – | Sell |
-135,716
| Closed | -$2.48M | – | 1580 |
|
|
2020
Q2 | $2.48M | Buy |
+135,716
| New | +$2.39M | 0.02% | 711 |
|
|
2019
Q3 | – | Sell |
-52,529
| Closed | -$1.32M | – | 1667 |
|
|
2019
Q2 | $1.32M | Buy |
+52,529
| New | +$1.25M | 0.01% | 866 |
|
|
2019
Q1 | – | Sell |
-368,526
| Closed | -$6.81M | – | 1714 |
|
|
2018
Q4 | $6.81M | Buy |
+368,526
| New | +$8.77M | 0.07% | 358 |
|
|
2018
Q3 | – | Sell |
-127,873
| Closed | -$2.97M | – | 1136 |
|
|
2018
Q2 | $2.97M | Buy |
+127,873
| New | +$2.64M | 0.04% | 372 |
|
|
2018
Q1 | – | Sell |
-142,832
| Closed | -$2.99M | – | 559 |
|
|
2017
Q4 | $2.99M | Buy |
+142,832
| New | +$2.27M | 0.13% | 149 |
|
|
2016
Q2 | – | Sell |
-67,054
| Closed | -$1.76M | – | 989 |
|
|
2016
Q1 | $1.76M | Buy |
67,054
+1,668
| +3% | +$123K | 0.02% | 588 |
|
|
2015
Q4 | $6.65M | Buy |
65,386
+28,365
| +77% | +$3.19M | 0.06% | 324 |
|
|
2015
Q3 | $6.6M | Sell |
37,021
-95,226
| -72% | -$22.2M | 0.08% | 248 |
|
|
2015
Q2 | $29.4M | Buy |
132,247
+127,241
| +2,542% | +$28.2M | 0.38% | 72 |
|
|
2015
Q1 | $994K | Sell |
5,006
-105,888
| -95% | -$18.8M | 0.01% | 579 |
|
|
2014
Q4 | $15.9M | Buy |
110,894
+57,638
| +108% | +$7.75M | 0.21% | 129 |
|
|
2014
Q3 | $6.99M | Buy |
+53,256
| New | +$6.35M | 0.1% | 238 |
|
|
2014
Q2 | – | Sell |
-6,254
| Closed | -$824K | – | 929 |
|
|
2014
Q1 | $824K | Buy |
+6,254
| New | +$855K | 0.02% | 515 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
Marshall Wace's BHC Position: Q1 2026 in Review
Marshall Wace sold out of Bausch Health (BHC) in Q1 2026, closing a stake of 604,481 shares — an estimated $4.2M sold.
Marshall Wace first reported a position in BHC in Q1 2014 and held it in 22 quarters. The position peaked at $29.4M in Q2 2015. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.
- Marshall Wace reported no remaining Bausch Health position as of Q1 2026 after selling out during the quarter.
- Marshall Wace sold 604,481 Bausch Health shares in Q1 2026, an estimated $4.2M.
- Marshall Wace first reported a position in Bausch Health in Q1 2014 and held it in 22 quarters.
- Marshall Wace's Bausch Health position peaked at $29.4M in Q2 2015.
- 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.